In addition to its importance in transfusion, Kell protein is a member of the M13 family of zinc endopeptidases and functions as an endothelin-3-converting enzyme. To obtain information on the structure of Kell protein we built a model based on the crystal structure of the ectodomain of neutral endopeptidase 24.11 (NEP). Similar to NEP, the Kell protein has 2 globular domains consisting mostly of ␣-helical segments. The domain situated closest to the membrane contains both the N-and C-terminal sequences and the enzyme-active site. The outer domain contains all of the amino acids whose substitutions lead to different Kell blood group phenotypes. In the model, the zinc peptidase inhibitor, phosphoramidon, was docked in the active site. Site-directed mutagenesis of amino acids in the active site was performed and the enzymatic activities of expressed mutant Kell proteins analyzed and compared with NEP.
IntroductionThe Kell blood group protein is a type II membrane glycoprotein that is important in transfusion medicine due to the immunogenicity of its many polymorphic forms. The primary structure of Kell protein and its enzyme function as an endothelin-converting enzyme, classifies it as a member of the neprilysin (M13) subfamily of zinc endopeptidases. Kell differs from other M13 members in that it is linked by a single disulfide bond to another protein, XK, which traverses the membrane 10 times (for reviews, see Lee et al 1,2 ). XK has the structural characteristics of a membrane transporter, but its function has not yet been determined. 3 As a group the mammalian M13 peptidases are involved in the activation of bioactive peptides by specific cleavages of larger inactive peptides and in the proteolysis of bioactive peptides. [4][5][6] The substrate specificities of the M13 family members vary with neutral endopeptidase (NEP; EC 3.4.24.11) 7 and secreted endopeptidase (SEP) 8 having a wide range of substrates and endothelinconverting enzyme 1 (ECE-1; EC 3.4.24.71), endothelin-converting enzyme 2 (ECE-2), 9,10 Kell, 11 and phosphate-regulating protein (PHEX) 12,13 with a restricted number of substrates. ECE-1 and ECE-2 preferentially cleave big endothelin-1-releasing endothelin-1 (ET-1) but can also cleave big endothelin-2 and big endothelin-3. 14 ECE-1 also hydrolyzes other bioactive peptides such as bradykinin, neurotensin, and substance P. 9 Kell, like ECE-1 and ECE-2, is also an endothelin-converting enzyme but, in contrast to ECE-1 and ECE-2, Kell preferentially cleaves big endothelin-3, releasing the active peptide endothelin-3 (ET-3) although it also, to a lesser degree, activates ET-1 and endothelin-2 (ET-2). 11 Thus far the parathyroid hormone-related fragment 107-139 and fibroblast growth factor 23 (FGF-23), which is involved in phosphate transport in the kidney, are the only known substrates for PHEX. 12,13 Substrates for XCE, which is mostly expressed in the central nervous system, have not yet been identified. 15,16 Site-directed mutagenesis of conserved amino acid residues in NEP have yielded valuab...